These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group. Parkinson Study Group JAMA; 2000 Oct; 284(15):1931-8. PubMed ID: 11035889 [TBL] [Abstract][Full Text] [Related]
3. Brain imaging to assess the effects of dopamine agonists on progression of Parkinson disease. Ahlskog JE; Maraganore DM; Uitti RJ; Uhl GR JAMA; 2002 Jul; 288(3):311; author reply 312-3. PubMed ID: 12117385 [No Abstract] [Full Text] [Related]
5. [Use of dopamine agonists in the treatment of Parkinson's disease]. Gekht AB Zh Nevrol Psikhiatr Im S S Korsakova; 2002; 102(9):54-8. PubMed ID: 12378886 [No Abstract] [Full Text] [Related]
10. The initial drug treatment of older patients with Parkinson's disease - consider an agonist, but don't demonise dopa. MacMahon DG Age Ageing; 2003 May; 32(3):244-5. PubMed ID: 12720606 [No Abstract] [Full Text] [Related]
11. Pramipexole and ropinirole for Parkinson's disease. Med Lett Drugs Ther; 1997 Nov; 39(1014):109-10. PubMed ID: 9398824 [No Abstract] [Full Text] [Related]
12. Pramipexole, ropinirole, and mania in Parkinson's disease. Singh A; Althoff R; Martineau RJ; Jacobson J Am J Psychiatry; 2005 Apr; 162(4):814-5. PubMed ID: 15800169 [No Abstract] [Full Text] [Related]
13. Short review on dopamine agonists: insight into clinical and research studies relevant to Parkinson's disease. Radad K; Gille G; Rausch WD Pharmacol Rep; 2005; 57(6):701-12. PubMed ID: 16382188 [TBL] [Abstract][Full Text] [Related]
14. Brain imaging to assess the effects of dopamine agonists on progression of Parkinson disease. Morrish PK JAMA; 2002 Jul; 288(3):312; author reply 312-3. PubMed ID: 12117387 [No Abstract] [Full Text] [Related]
15. Brain imaging to assess the effects of dopamine agonists on progression of Parkinson disease. Albin RL; Nichols TE; Frey KA JAMA; 2002 Jul; 288(3):311-2; author reply 312-3. PubMed ID: 12117386 [No Abstract] [Full Text] [Related]
16. Combination of two different dopamine agonists in the management of Parkinson's disease. Stocchi F; Berardelli A; Vacca L; Thomas A; De Pandis MF; Modugno N; Valente M; Ruggieri S Neurol Sci; 2002 Sep; 23 Suppl 2():S115-6. PubMed ID: 12548370 [TBL] [Abstract][Full Text] [Related]
17. Pramipexole--a new dopamine agonist for the treatment of Parkinson's disease. Bennett JP; Piercey MF J Neurol Sci; 1999 Feb; 163(1):25-31. PubMed ID: 10223406 [TBL] [Abstract][Full Text] [Related]
18. Several classes of new drugs emerging for Parkinson disease. Phillips P JAMA; 1999 Sep; 282(10):929-31. PubMed ID: 10485664 [No Abstract] [Full Text] [Related]